Development of a novel Gateway-based vector system for efficient, multiparallel protein expression in Escherichia coli

被引:19
作者
Freuler, Felix [1 ]
Stettler, Thomas [1 ]
Meyerhofer, Marco [1 ]
Leder, Lukas [1 ]
Mayr, Lorenz M. [1 ]
机构
[1] CPC, NIBR, CH-4056 Basel, Switzerland
关键词
fusion proteins; protein expression; protein labeling; recombination cloning; multiparallel expression;
D O I
10.1016/j.pep.2008.02.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We describe a cloning and expression system which is based on the Escherichia coli T7 expression system and Gateway recombination technology. We have produced numerous destination vectors with selected fusion tags and an additional set of entry vectors containing the gene of interest and optional labeling tags. This powerful system enables us to transfer a cDNA to several expression vectors in parallel and combine them with various labeling tags. To remove the attached amino terminal tags along with the unwanted attB1 site, we inserted PreScission protease cleavage sites. In contrast to the commercially available destination vectors, our plasmids provide kanamycin resistance, which can be an advantage when expressing toxic proteins in E coli. Some small-scale protein expression experiments are shown to demonstrate the usefulness of these novel Gateway vectors. In summary, this system has some benefits over the widely used and commercially available Gateway standard system, and it enables many different combinations for expression constructs from a single gene of interest. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:232 / 241
页数:10
相关论文
共 13 条
[1]   Construction of a set Gateway-based destination vectors for high-throughput cloning and expression screening in Escherichia coli [J].
Busso, D ;
Delagoutte-Busso, B ;
Moras, D .
ANALYTICAL BIOCHEMISTRY, 2005, 343 (02) :313-321
[2]  
CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062
[3]   Production of soluble mammalian proteins in Escherichia coli:: identification of protein features that correlate with successful expression -: art. no. 32 [J].
Dyson, MR ;
Shadbolt, SP ;
Vincent, KJ ;
Perera, RL ;
McCafferty, J .
BMC BIOTECHNOLOGY, 2004, 4 (1)
[4]   Optimization of protein expression systems for modern drug discovery [J].
Forstner, Michael ;
Leder, Lukas ;
Mayr, Lorenz M. .
EXPERT REVIEW OF PROTEOMICS, 2007, 4 (01) :67-78
[5]   Cloning technologies for protein expression and purification [J].
Hartley, James L. .
CURRENT OPINION IN BIOTECHNOLOGY, 2006, 17 (04) :359-366
[6]   DNA cloning using in vitro site-specific recombination [J].
Hartley, JL ;
Temple, GF ;
Brasch, MA .
GENOME RESEARCH, 2000, 10 (11) :1788-1795
[7]   A Rubredoxin based system for screening of protein expression conditions and on-line monitoring of the purification process [J].
Kohli, BM ;
Ostermeier, C .
PROTEIN EXPRESSION AND PURIFICATION, 2003, 28 (02) :362-367
[8]  
Leder L, 2007, CURR OPIN DRUG DISC, V10, P193
[9]   β-site specific intrabodies to decrease and prevent generation of Alzheimer's Aβ peptide [J].
Paganetti, P ;
Calanca, V ;
Galli, C ;
Stefani, M ;
Molinari, M .
JOURNAL OF CELL BIOLOGY, 2005, 168 (06) :863-868
[10]   USE OF BACTERIOPHAGE-T7 RNA-POLYMERASE TO DIRECT SELECTIVE HIGH-LEVEL EXPRESSION OF CLONED GENES [J].
STUDIER, FW ;
MOFFATT, BA .
JOURNAL OF MOLECULAR BIOLOGY, 1986, 189 (01) :113-130